| A multifactorial trial design to assess combination therapy in hypertension: treatment with bisoprolol and hydrochlorothiazide WH Frishman, BS Bryzinski, LR Coulson, VL DeQuattro, ND Vlachakis, ... Archives of internal medicine 154 (13), 1461-1468, 1994 | 278 | 1994 |
| Patient-reported outcomes: measurement, implementation and interpretation JC Cappelleri, KH Zou, AG Bushmakin, JMJ Alvir, D Alemayehu, ... Crc Press, 2013 | 249 | 2013 |
| Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment LM Prisant, MR Weir, V Papademetriou, MA Weber, IA Adegbile, ... American heart journal 130 (2), 359-366, 1995 | 159 | 1995 |
| First‐line therapy option with low‐dose bisoprolol fumarate and low‐dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension WH Frishman, JF Burris, WJ Mroczek, MR Weir, D Alemayehu, JS Simon, ... The Journal of Clinical Pharmacology 35 (2), 182-188, 1995 | 118 | 1995 |
| Applications of ROC analysis in medical research: recent developments and future directions D Alemayehu, KH Zou Academic radiology 19 (12), 1457-1464, 2012 | 88 | 2012 |
| Antihypertensive therapy and quality of life: Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy MR Weir, LM Prisant, V Papademetriou, MA Weber, IA Adegbile, ... American journal of hypertension 9 (9), 854-859, 1996 | 45 | 1996 |
| A comparative study of subgroup identification methods for differential treatment effect: performance metrics and recommendations D Alemayehu, Y Chen, M Markatou Statistical Methods in Medical Research 27 (12), 3658-3678, 2018 | 36 | 2018 |
| Big Data: transforming drug development and health policy decision making D Alemayehu, ML Berger Health Services and Outcomes Research Methodology 16, 92-102, 2016 | 35 | 2016 |
| Conceptual and analytical considerations toward the use of patient-reported outcomes in personalized medicine D Alemayehu, JC Cappelleri American health & drug benefits 5 (5), 310, 2012 | 28 | 2012 |
| Statistical issues with the analysis of nonrandomized studies in comparative effectiveness research D Alemayehu, B Jones, RJ Willke Journal of Managed Care Pharmacy 17 (9 Supp A), S22-S26, 2011 | 27 | 2011 |
| Bisoprolol, a once‐a‐day beta‐blocking agent for patients with mild to moderate hypertension ME Davidov, SP Singh, ND Vlachakis, JB Blumenthal, JS Simon, ... Clinical cardiology 17 (5), 263-268, 1994 | 27 | 1994 |
| A paradigm shift in drug development for treatment of rare multidrug-resistant gram-negative pathogens D Alemayehu, J Quinn, J Cook, M Kunkel, CA Knirsch Clinical infectious diseases 55 (4), 562-567, 2012 | 22 | 2012 |
| Therapy in Hypertension ND Vlachakis, G Dukart, JD Goldberg, D Alemayehu Arch Intern Med 154, 1461-1468, 1994 | 19 | 1994 |
| Perspectives on virtual (remote) clinical trials as the “new normal” to accelerate drug development D Alemayehu, R Hemmings, K Natarajan, S Roychoudhury Clinical Pharmacology & Therapeutics 111 (2), 373-381, 2022 | 18 | 2022 |
| Improving conduct and feasibility of clinical trials to evaluate antibacterial drugs to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial … C Knirsch, D Alemayehu, R Botgros, S Comic-Savic, D Friedland, ... Clinical Infectious Diseases 63 (suppl_2), S29-S36, 2016 | 18 | 2016 |
| Revisiting issues, drawbacks and opportunities with observational studies in comparative effectiveness research D Alemayehu, JC Cappelleri Journal of Evaluation in Clinical Practice 19 (4), 579-583, 2013 | 16 | 2013 |
| Examination of Data, Analytical Issues and Proposed Methods for Conducting Comparative Effectiveness Research Using" Real-World Data" D Alemayehu, R Ali, JMJ Alvir, JC Cappelleri, MJ Cziraky, B Jones, ... Journal of Managed Care Pharmacy 17 (9 Supp A), 1-37, 2011 | 15 | 2011 |
| Perspectives on pooled data analysis: The case for an integrated approach D Alemayehu J. Data Sci. 9, 389-397, 2011 | 13 | 2011 |
| Vaccines: A review of immune‐based interventions to prevent and treat disease D Alemayehu, E Utt, C Knirsch The Journal of Clinical Pharmacology 55 (S3), S93-S102, 2015 | 11 | 2015 |
| Considerations on the use of patient-reported outcomes in comparative effectiveness research D Alemayehu, RJ Sanchez, JC Cappelleri Journal of Managed Care Pharmacy 17 (9 Supp A), S27-S33, 2011 | 11 | 2011 |
